semaglutide + cagrilintide & in Overweight Adults (REDEFINE-1) | NEJM CagriSema guide 2026: FDA approval,

We know you're not a doctor, but you do work with the doctors and you know how to advise in this realm

As a structural analog within the copper peptide class, it has been examined alongside GHK-Cu in preclinical models investigating copper-dependent enzymatic activity, extracellular matrix remodeling, and cellular signaling pathways relevant to skin and connective tissue biology

Learn more about BPC-157 therapy and how it may support your recovery goals

Our clinical staff are true specialists, backed by a team of 25+ board-certified dermatologists and overseen by our Chief Medical Officer to ensure your care meets the highest medical standards